Clinical Trials Logo

Clinical Trial Summary

This is a supplement study being conducted to find out if collision sport athletes who are exposed to repetitive head impacts while supplementing with carotenoids will have decreased pro-inflammatory blood biomarkers, increases in macular pigment optical density, improved contrast sensitivity, greater retinal nerve fiber thickness, and better overall visual quality of life scores compared to collision athletes taking a placebo.


Clinical Trial Description

Originally adapted to augment macular pigment for anti-inflammatory, antioxidative, blue light, and visual performance purposes, supplementation with carotenoids has been tested in animal models for protective effects against traumatic brain injury (TBI). Results have been promising, as mice provided with the three main carotenoids (Lutein, Meso-Zeaxanthin, and Zeaxanthin) following TBI displayed reduced levels of pro-inflammatory markers (IL-1β, IL-6, and GFAP) and increased levels of GAP43, NCAM, and BDNF, signaling activation of anti-oxidant systems. Due to inflammation of the visual system following trauma, immune responses in the eye are for both reparative and protective purposes. However, cytokines released by immune cells compromise visual acuity by means of inflammation and fibrosis (scarring). As such, inflammation to the visual system (including visual processing structures in the brain) carries the danger of visual impairment. Research examining chronic inflammatory responses in the optic tract and subsequent visual dysfunction found mTBI in rodent models to increase GFAP, tumor necrosis factor (TNF), and degeneration of axons up to 3.5 months post-injury. As such, inflammation of the visual system is a measurable phenomenon in rodent models, conveying the need for human subjects research. The nutrients found in the proposed test supplement, lutein, zeaxanthin, meso-zeaxanthin, along with the omega-3 fatty acids DHA and EPA, are deposited in the brain regions that are often found to be affected by a collision-related head injury. Thus, an exploratory study of this topic is proposed, utilizing the three main carotenoids in the form of a MacuHealth supplement. Optical Coherence Tomography has become a critical clinical tool when discovering and diagnosing disease and neurological disorders of the eyes. It works to map the retina in order to give ophthalmologists precise measurements of the tissues which make up this important part of human anatomy and helps medical experts to diagnosis diseases of the eye such as Glaucoma and Macular Degeneration. In terms of retinal nerve fiber layer thickness (RNFL), a study found Olympic boxers to have thinner RNFL compared to controls. Another study found RNFL thickness as a significant predictor of athlete vs control status, with 4.8-um of thinning seen on average in athletes (boxing, football) when compared to controls. Although vision disorders are so common, VQOL - to our knowledge - is not specifically addressed following exposure to repetitive head impacts (RHI), concussion, or during return-to-play protocol. In sports such as football, hockey, and boxing where participants are exposed to RHI, participation while experiencing decreased VQOL or visual functionality could prove costly to the health of those athletes. Poor visual acuity and photophobia following concussion have been cited as indicators of poor VQOL. As such, use of the VFQ-25 and the 10-Item Supplement may be important additions to current clinical practice when evaluating the baseline health status of athletes, and following the completion of a collision-sport season. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06270680
Study type Interventional
Source Penn State University
Contact Semyon Slobounov, PhD
Phone 8145714298
Email sms18@psu.edu
Status Not yet recruiting
Phase Early Phase 1
Start date August 1, 2024
Completion date December 20, 2024

See also
  Status Clinical Trial Phase
Terminated NCT00754169 - Warfighter Head Injury Study N/A
Completed NCT03164434 - Influence of Drainage on EVD ICP-signal
Completed NCT00993252 - Canadian Computed Tomography (CT) Head Rule Study Phase 3
Active, not recruiting NCT03441867 - Neuroimaging Biomarker for Seizures N/A
Active, not recruiting NCT05400551 - Craneofacial Injuries in Rink Hockey Athletes
Completed NCT00295074 - The Effect of Mild Traumatic Brain Injury on Recovery From Injury N/A
Completed NCT00001192 - Neuropsychological Evaluation of Psychiatric and Neurological Patients N/A
Recruiting NCT05326555 - Dynamic Vision Testing and Concussion Management Dream Team 65
Completed NCT03674398 - Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology N/A
Completed NCT02650765 - S100 Biomarker in the Acute Management of Mild Head Injuries
Completed NCT02368366 - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI N/A
Active, not recruiting NCT05629169 - Video Review of the Frequency and Assessment of Head Impacts During the FIFA World Cup 2022TM
Completed NCT02357186 - Broad Validation Study of a Management Algorithm Mild Head Injury in Children
Recruiting NCT05562050 - Characteristics of the Anosmic Olfactory Mucosa
Recruiting NCT04212754 - Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury
Recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI
Completed NCT02752711 - Validation of the PECARN Clinical Decision Rule for Children With Minor Head Trauma N/A
Recruiting NCT05663034 - CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms N/A
Completed NCT04499937 - ReCoUPS: Post-Concussion Patient Reports N/A
Completed NCT01858675 - Biomarkers Correlation With Volemia N/A